BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10872429)

  • 1. Pancreatic cancer surveillance in a high-risk cohort. Is it worth the cost?
    Martin SP; Ulrich CD
    Med Clin North Am; 2000 May; 84(3):739-47, xii-xiii. PubMed ID: 10872429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for early pancreatic ductal adenocarcinoma in hereditary pancreatitis.
    Howes N; Greenhalf W; Neoptolemos J
    Med Clin North Am; 2000 May; 84(3):719-38, xii. PubMed ID: 10872428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factors, receptors, and molecular alterations in pancreatic cancer. Putting it all together.
    Ulrich CD
    Med Clin North Am; 2000 May; 84(3):697-705, xi-xii. PubMed ID: 10872426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Strategies for screening for pancreatic adenocarcinoma in high-risk patients: the place of endoscopic ultrasound].
    Béchade D
    Presse Med; 2011 Mar; 40(3):230-8. PubMed ID: 21211938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer surveillance of patients from familial pancreatic cancer kindreds.
    Brentnall TA
    Med Clin North Am; 2000 May; 84(3):707-18. PubMed ID: 10872427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of early pancreatic ductal adenocarcinoma in high-risk patients.
    Wong T; Howes N; Threadgold J; Smart HL; Lombard MG; Gilmore I; Sutton R; Greenhalf W; Ellis I; Neoptolemos JP
    Pancreatology; 2001; 1(5):486-509. PubMed ID: 12120229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is screening for pancreatic cancer in high-risk groups cost-effective? - Experience from a Danish national screening program.
    Joergensen MT; Gerdes AM; Sorensen J; Schaffalitzky de Muckadell O; Mortensen MB
    Pancreatology; 2016; 16(4):584-92. PubMed ID: 27090585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group.
    Lowenfels AB; Maisonneuve P; Whitcomb DC
    Med Clin North Am; 2000 May; 84(3):565-73. PubMed ID: 10872414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgery for lesions at risk for pancreatic cancer].
    Sauvanet A
    Rev Prat; 2015 Mar; 65(3):371-5. PubMed ID: 26016199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
    Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
    Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical and economic evaluation of endoscopic ultrasound for patients at risk for familial pancreatic adenocarcinoma.
    Rubenstein JH; Scheiman JM; Anderson MA
    Pancreatology; 2007; 7(5-6):514-25. PubMed ID: 17912015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of pancreatic cancer: why, who, and how to screen.
    Klapman J; Malafa MP
    Cancer Control; 2008 Oct; 15(4):280-7. PubMed ID: 18813195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.
    Vasen HF; Wasser M; van Mil A; Tollenaar RA; Konstantinovski M; Gruis NA; Bergman W; Hes FJ; Hommes DW; Offerhaus GJ; Morreau H; Bonsing BA; de Vos tot Nederveen Cappel WH
    Gastroenterology; 2011 Mar; 140(3):850-6. PubMed ID: 21129377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds.
    Rulyak SJ; Kimmey MB; Veenstra DL; Brentnall TA
    Gastrointest Endosc; 2003 Jan; 57(1):23-9. PubMed ID: 12518126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer screening: state of the art.
    Gemmel C; Eickhoff A; Helmstädter L; Riemann JF
    Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):89-96. PubMed ID: 19210116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strategies for screening for pancreatic adenocarcinoma in high-risk patients].
    Béchade D
    Bull Cancer; 2011 Jul; 98(7):827-36. PubMed ID: 21684836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary pancreatitis].
    Jørgensen MT; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2003 Jan; 165(5):447-51. PubMed ID: 12599840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary pancreatitis and secondary screening for early pancreatic cancer.
    Vitone LJ; Greenhalf W; Howes NR; Neoptolemos JP
    Rocz Akad Med Bialymst; 2005; 50():73-84. PubMed ID: 16358943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising outcomes of screening for pancreatic cancer by genetic testing and endoscopic ultrasound.
    Sud A; Wham D; Catalano M; Guda NM
    Pancreas; 2014 Apr; 43(3):458-61. PubMed ID: 24622079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.